Explore

Rapid Read Rapid Read
AI-Enabled Digital Stethoscope Doubles Detection Rate of Heart Disease

AI-Enabled Digital Stethoscope Doubles Detection Rate of Heart Disease

A new study published in the European Heart Journal – Digital Health reveals that an AI-enabled digital stethoscope is twice as effective as traditional stethoscopes in detecting valvular heart disease (VHD). Conducted in the U.S., the study involved 357 patients over the age of 50 and demonstrated a 92.3% sensitivity rate for the AI tool, compared to 46.2% for standard exams. This significant improvement suggests that many heart valve issues are currently being missed in primary care settings.
Discover daily Discover daily
How St. Jude Pays for Free Care: Inside the Donation-Driven Model That Funds the Hospital

How St. Jude Pays for Free Care: Inside the Donation-Driven Model That Funds the Hospital

Jude Children's Research Hospital is a unique institution in the realm of pediatric healthcare, not only for its groundbreaking research and treatm...
Trendline Trendline
Aetna Enhances Digital Onboarding for New Health Plan Members

Aetna Enhances Digital Onboarding for New Health Plan Members

Aetna Enhances Digital Onboarding for New Health Plan Members
Trendline Trendline
PharmaResearch Gains FDA Approval for Phase 1 Trial of Nano Anticancer Drug PRD-101

PharmaResearch Gains FDA Approval for Phase 1 Trial of Nano Anticancer Drug PRD-101

PharmaResearch Gains FDA Approval for Phase 1 Trial of Nano Anticancer Drug PRD-101
Rapid Read Rapid Read
CIRM Launches $100 Million Initiative for Rare Genetic Disease Therapies

CIRM Launches $100 Million Initiative for Rare Genetic Disease Therapies

The California Institute for Regenerative Medicine (CIRM) has announced a new $100 million funding initiative aimed at accelerating gene therapies for rare diseases. The program, known as the Rare Disease Acceleration Platform and Innovation and Delivery (RAPID), seeks to move away from traditional single-therapy approaches by developing scalable, platform-based genetic therapies. This initiative is inspired by the success of a personalized CRISPR therapy for a rare genetic disorder and aims to address the needs of over 30 million people in the U.S. affected by rare diseases.
Rapid Read Rapid Read
George Coukos Appointed Director of Ludwig Laboratory for Cell Therapy, Advancing Cancer Immunotherapy

George Coukos Appointed Director of Ludwig Laboratory for Cell Therapy, Advancing Cancer Immunotherapy

The Ludwig Institute for Cancer Research has announced the establishment of the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine, led by Dr. George Coukos. Dr. Coukos, a renowned expert in tumor immunology and cellular immunotherapy, returns to the U.S. after a transformative tenure in Switzerland. His leadership is expected to advance the development of cellular-based cancer therapies, focusing on personalized treatments for various malignancies. The laboratory aims to enhance the specificity and potency of immune cells used in cancer treatment, addressing challenges like tumor heterogeneity and immunosuppressive environments.
Trendline Trendline
Indox Acquires 'Bucks Harbor' for Berlinale Premiere, Highlighting Maine's Coastal Life

Indox Acquires 'Bucks Harbor' for Berlinale Premiere, Highlighting Maine's Coastal Life

Indox Acquires 'Bucks Harbor' for Berlinale Premiere, Highlighting Maine's Coastal Life
AP News AP News
Envoys push a US plan for ending Russia's war in Ukraine

Envoys push a US plan for ending Russia's war in Ukraine

The U.S.-led push to end Russia’s nearly 4-year-old war in Ukraine gained momentum late last year and is moving ahead in 2026, with leaders, diplomats and envoys working on trying to reach a deal
Trendline Trendline
U.S. Biotech Leaders Warn of Industry Shift Towards China Amid Strategic Challenges

U.S. Biotech Leaders Warn of Industry Shift Towards China Amid Strategic Challenges

U.S. Biotech Leaders Warn of Industry Shift Towards China Amid Strategic Challenges
Trendline Trendline
Acarix Achieves EU MDR Certification for CADScor System, Aiming for U.S. Market Expansion

Acarix Achieves EU MDR Certification for CADScor System, Aiming for U.S. Market Expansion

Acarix Achieves EU MDR Certification for CADScor System, Aiming for U.S. Market Expansion
Trendline Trendline
Lirio's Agentic AI Aims to Transform Life Sciences with Hyper-Personalized Engagement

Lirio's Agentic AI Aims to Transform Life Sciences with Hyper-Personalized Engagement

Lirio's Agentic AI Aims to Transform Life Sciences with Hyper-Personalized Engagement
Rapid Read Rapid Read
Lotus Health Secures $35M to Expand AI-Driven Free Healthcare Services

Lotus Health Secures $35M to Expand AI-Driven Free Healthcare Services

Lotus Health, a startup offering AI-driven primary care services, has raised $35 million in a Series A funding round led by CRV and Kleiner Perkins. The company, founded by KJ Dhaliwal, aims to address inefficiencies in the U.S. healthcare system by providing free, AI-assisted medical care. Lotus Health's platform is available 24/7 in 50 languages and offers services such as diagnosis, prescriptions, and specialist referrals. The AI system is supported by board-certified human doctors who review final medical decisions. This funding will help Lotus Health expand its services and continue developing its AI technology.